MXD3 and cancer: As a consequence, MXD3 emerges as a promising early biomarker for cancer surveillance and diagnosis.[29] As there are few studies on the connection between MXD3 and hip pain at the moment, additional experiments are required to determine the molecular pathways that connect these 2 illnesses.